LeMaitre Vascular's Engagement in November Conferences
LeMaitre Vascular, Inc. (Nasdaq: LMAT) is gearing up for an exciting month as they announce participation in three prominent investor conferences throughout November. These events mark a significant opportunity for the company to share insights into their innovative technologies and commitment to improving patient outcomes in vascular care.
Upcoming Conferences Overview
The first event on their agenda is the UBS Global Healthcare Conference, where David Roberts, President of LeMaitre Vascular, will showcase the company's advancements in medical technology. Scheduled for November 13, this conference will take place at the elegant Terranea Resort in Rancho Palos Verdes, California, with Mr. Roberts’ presentation beginning at 7:15 AM PT.
Stifel's 2024 Healthcare Conference
Continuing the momentum, LeMaitre Vascular will participate in Stifel's 2024 Healthcare Conference on November 19. This event in New York City provides the platform for another important presentation by David Roberts. Attendees can look forward to his talk, which is set for 1:50 PM ET, giving insights into the company's strategic initiatives and product line.
Wolfe Research Healthcare Conference 2024
The series of conferences culminates at the Wolfe Research Healthcare Conference on November 20. Again, David Roberts will represent LeMaitre Vascular, presenting at 2:00 PM ET at Wolfe Research’s headquarters in New York City. This gathering promises to be an insightful experience for investors eager to learn more about LeMaitre’s performance and vision.
About LeMaitre Vascular
LeMaitre Vascular stands at the forefront of the medical device industry with a dedicated focus on peripheral vascular disease, a serious condition that affects over 200 million individuals globally. Their commitment to developing, manufacturing, and marketing both disposable and implantable vascular devices positions them as a trusted partner to vascular surgeons everywhere. Each device contributes significantly to the surgical treatment and care of patients, ensuring that the needs of healthcare providers are met with high-quality solutions.
Why Attend These Conferences?
Attending these conferences provides stakeholders a unique opportunity to engage directly with LeMaitre's leadership, understanding their strategic direction and technological innovations. For investors, this is a chance to glean insights into the performance metrics and future outlook of the company as they navigate the evolving landscape of healthcare.
Frequently Asked Questions
What is the significance of LeMaitre's participation in investor conferences?
LeMaitre’s participation in these conferences allows them to showcase their innovations, strengthen investor relationships, and provide updates on company performance and future goals.
Who will represent LeMaitre at these events?
David Roberts, the President of LeMaitre Vascular, will be the key presenter at all three conferences, sharing insights and updates about the company.
Where will the UBS Global Healthcare Conference take place?
The UBS Global Healthcare Conference is set to be held at the Terranea Resort, Rancho Palos Verdes, California.
What industry does LeMaitre Vascular operate in?
LeMaitre Vascular operates within the medical device industry, focusing primarily on developing solutions for peripheral vascular diseases.
How can I find more information about LeMaitre's products?
Additional details about LeMaitre Vascular's product offerings and innovations can be found on their official website.
